No Data
Express News | Lexicon Appoints Ivan H. Cheung to Board of Directors
Press Release: Lexicon Appoints Ivan H. Cheung to Board of Directors
Lexicon Pharmaceuticals (NASDAQ:LXRX Investor Three-year Losses Grow to 80% as the Stock Sheds US$107m This Past Week
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations Is Among Four Lexicon-Supported Presentations at the American Heart Association's (AHA) Sessions 2024 in Chicago
Express News | Lexicon Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $4 From $5
Lexicon Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results.